2014 ESC/ESA Guidelines on non-cardiac surgery: Cardiovascular assessment and management

European Journal of Anaesthesiology

Volumn 31, Issue 10, 2014, Pages 517-573

  Kristensen, Steen Dalby ^a   Knuuti, Juhani ^b   Saraste, Antti ^b   Anker, Stefan ^c   Bøtker, Hans Erik ^a   De Hert, Stefan ^c   Ford, Ian ^c   Juanatey, Jose Ramón Gonzalez ^c   Gorenek, Bulent ^c   Heyndrickx, Guy Robert ^c   Hoeft, Andreas ^c   Huber, Kurt ^c   Iung, Bernard ^c   Kjeldsen, Keld Per ^a   Longrois, Dan ^c   Luescher, Thomas F ^c   Pierard, Luc ^c   Pocock, Stuart ^c   Price, Susanna ^c   Roffi, Marco ^c   Sirnes, Per Anton ^c   Uva, Miguel Sousa ^c   Voudris, Vasilis ^c   Funck Brentano, Christian ^c   more..

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c NONE   (Greece)

Author keywords

Anaesthesiology; Anti thrombotic therapy; Arrhythmias; Beta blockers; Cerebrovascular disease; Guidelines; Heart failure; Non cardiac surgery; Perioperative cardiac management; Postoperative cardiac surveillance; Preoperative cardiac risk assessment; Preoperative cardiac testing; Preoperative coronary artery revascularization; Pulmonary disease; Renal disease; Valvular disease

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTIVITAMIN K; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC ACID DERIVATIVE; SEVOFLURANE;

ANALGESIA; ANEMIA; ANESTHESIOLOGY; ANGIOCARDIOGRAPHY; ANTICOAGULANT THERAPY; AORTA STENOSIS; AORTA VALVE REGURGITATION; ASYMPTOMATIC DISEASE; BACTERIAL ENDOCARDITIS; BRADYCARDIA; CARDIAC PATIENT; CARDIOLOGY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR DISEASE ASSESSMENT; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CONGENITAL HEART DISEASE; DIURETIC THERAPY; EARLY DIAGNOSIS; ELECTROCARDIOGRAPHY; ENDOVASCULAR SURGERY; FUNCTIONAL STATUS; GLUCOSE METABOLISM; HEART ATRIUM FIBRILLATION; HEART CATHETERIZATION; HEART FAILURE; HEART MUSCLE REVASCULARIZATION; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VALVE PROSTHESIS; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERTENSION; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INFECTION PREVENTION; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; LAPAROSCOPIC SURGERY; LUNG DISEASE; MEDICAL SOCIETY; META ANALYSIS (TOPIC); MITRAL VALVE REGURGITATION; MITRAL VALVE STENOSIS; PERIOPERATIVE PERIOD; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PAIN; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PREOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK REDUCTION; SURGICAL RISK; THORACOSCOPY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; VALVULAR HEART DISEASE; ADVISORY COMMITTEE; CARDIOVASCULAR DISEASES; DISEASE MANAGEMENT; EUROPE; PROCEDURES; STANDARDS;

ADVISORY COMMITTEES; ANESTHESIOLOGY; CARDIOLOGY; CARDIOVASCULAR DISEASES; DISEASE MANAGEMENT; EUROPE; HUMANS; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL;

EID: 84924102176     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0000000000000150     Document Type: Review

References (279)

1. Weiser TG, Regenbogen SE, Thompson KD, et al. An estimation of the global volume of surgery: A modelling strategy based on available data. Lancet 2008; 372: 139-144.
2. Haynes AB, Weiser TG, Berry WR, et al. A surgical safety checklist to reduce morbidity and mortality in a global population. N Engl J Med 2009; 360: 491-499.
3. Devereaux PJ, Chan MT, Alonso-Coello P, et al. Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA 2012; 307: 2295-2304.
4. Naughton C, Feneck RO. The impact of age on 6-month survival in patients with cardiovascular risk factors undergoing elective noncardiac surgery. Int J Clin Pract 2007; 61: 768-776.
5. Mangano DT. Perioperative medicine: NHLBI working group deliberations and recommendations. J Cardiothorac Vasc Anesth 2004; 18: 1-6.
6. Ferguson TB, Hammill BG, Peterson ED, et al. A decade of change -Risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990-1999: A report from the STS National Database Committee and the Duke Clinical Research Institute. Ann Thorac Surg 2002; 73: 480-489.
7. Carroll K, Majeed A, Firth C, Gray J. Prevalence and management of coronary heart disease in primary care: Population-based crosssectional study using a disease register. J Public Health Med 2003; 25: 29-35.
8. Fletcher HR, Milhoan LH, Evans K, Austin PN. Patients with aortic stenosis: Who should undergo noncardiac surgery in a rural hospital? J Perianesth Nurs 2013; 28: 368-376.
9. Wirthlin DJ, Cambria RP. Surgery-specific considerations in the cardiac patient undergoing noncardiac surgery. Prog Cardiovasc Dis 1998; 40: 453-468.
10. Guay J, Choi P, Suresh S, et al. Neuraxial blockade for the prevention of postoperative mortality and major morbidity: An overview of Cochrane systematic reviews. Cochrane Database Syst Rev 2014; 1: CD010108.
11. Glance LG, Lustik SJ, Hannan EL, et al. The Surgical Mortality Probability Model: Derivation and validation of a simple risk prediction rule for noncardiac surgery. Ann Surg 2012; 255: 696-702.
12. Wang CL, Qu G, Xu HW. The short-And long-Term outcomes of laparoscopic versus open surgery for colorectal cancer: A meta-Analysis. Int J Colorectal Dis 2014.
13. Rosenmüller MH, Thorén Örnberg M, Myrnäs T, et al. Expertise-based randomized clinical trial of laparoscopic versus small-incision open cholecystectomy. Br J Surg 2013; 100: 886-894.
14. Bauer SM, Cayne NS, Veith FJ. New developments in the preoperative evaluation and perioperative management of coronary artery disease in patients undergoing vascular surgery. J Vasc Surg 2010; 51: 242-251.
15. Brown LC, Powell JT, Thompson SG, et al. The UK EndoVascular Aneurysm Repair (EVAR) trials: Randomised trials of EVAR versus standard therapy. Health Technol Assess 2012; 16: 1-218.
16. Stather PW, Sidloff D, Dattani N, et al. Systematic review and meta-Analysis of the early and late outcomes of open and endovascular repair of abdominal aortic aneurysm. Br J Surg 2013; 100: 863-872.
17. Paravastu SC, Jayarajasingam R, Cottam R, et al. Endovascular repair of abdominal aortic aneurysm. Cochrane Database Syst Rev 2014; 1: CD004178.
18. Antoniou GA, Chalmers N, Georgiadis GS, et al. A meta-Analysis of endovascular versus surgical reconstruction of femoropopliteal arterial disease. J Vasc Surg 2013; 57: 242-253.
19. Tendera M, Aboyans V, Bartelink ML, et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: The Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J 2011; 32: 2851-2906.
20. Liu ZJ, Fu WG, Guo ZY, et al. Updated systematic review and metaanalysis of randomized clinical trials comparing carotid artery stenting and carotid endarterectomy in the treatment of carotid stenosis. Ann Vasc Surg 2012; 26: 576-590.
21. Cutlip DE, Pinto DS. Extracranial carotid disease revascularization. Circulation 2012; 126: 2636-2644.
22. Naylor AR. Time to rethink management strategies in asymptomatic carotid artery disease. Nat Rev Cardiol 2012; 9: 116-124.
23. Nallamothu BK, Gurm HS, Ting HH, et al. Operator experience and carotid stenting outcomes in Medicare beneficiaries. JAMA 2011; 306: 1338-1343.
24. Holte K, Kehlet H. Postoperative ileus: A preventable event. Br J Surg 2000; 87: 1480-1493.
25. Popescu WM, Bell R, Duffy AJ, et al. A pilot study of patients with clinically severe obesity undergoing laparoscopic surgery: Evidence for impaired cardiac performance. J Cardiothorac Vasc Anesth 2011; 25: 943-949.
26. Lestar M,Gunnarsson L, Lagerstrand L, Wiklund P, Odeberg-Wernerman S. Hemodynamic perturbations during robot-Assisted laparoscopic radical prostatectomy in 458 Trendelenburg position. Anesth Analg 2011; 113: 1069-1075.
27. Hirvonen EA, Nuutinen LS, Kauko M. Hemodynamic changes due to Trendelenburg positioning and pneumoperitoneum during laparoscopic hysterectomy. Acta Anaesthesiol Scand 1995; 39: 949-955.
28. Nguyen NT, Wolfe BM. The physiologic effects of pneumoperitoneum in the morbidly obese. Annals of Surgery 2005; 241: 219-226.
29. Keus F, Gooszen HG, van Laarhoven CJ. Open, small-incision, or laparoscopic cholecystectomy for patients with symptomatic cholecystolithiasis An overview of Cochrane Hepato-Biliary Group reviews. Cochrane Database Syst Rev 2010; CD008318.
30. Mamidanna R, Burns EM, Bottle A, et al. Reduced risk of medical morbidity and mortality in patients selected for laparoscopic colorectal resection in England: A population-based study. Arch Surg 2012; 147: 219-227.
31. Cirocchi R, Farinella E, Trastulli S, et al. Elective sigmoid colectomy for diverticular disease. Laparoscopic vs open surgery: A systematic review. Colorectal Dis 2012; 14: 671-683.
32. Murr MM, Martin T, Haines K, et al. A state-wide review of contemporary outcomes of gastric bypass in Florida: Does provider volume impact outcomes? Ann Surg 2007; 245: 699-706.
33. Grailey K, Markar SR, Karthikesalingam A, et al. Laparoscopic versus open colorectal resection in the elderly population. Surg Endosc 2013; 27: 19-30.
34. Cao C, Manganas C, Ang SC, et al. Video-Assisted thoracic surgery versus open thoracotomy for nonsmall cell lung cancer: A meta-Analysis of propensity score-matched patients. Interact Cardiovasc Thorac Surg 2013; 16: 244-249.
35. De Martino RR, Brooke BS, Robinson W, et al. Designation as 'unfit for open repair' is associated with poor outcomes after endovascular aortic aneurysm repair. Circ Cardiovasc Qual Outcomes 2013; 6: 575-581.
36. Hlatky MA, Boineau RE, Higginbotham MB, et al. A brief self-Administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol 1989; 64: 651-654.
37. Fletcher GF, Balady GJ, Amsterdam EA, et al. Exercise standards for testing and training -A statement for healthcare professionals from the American Heart Association. Circulation 2001; 104: 1694-1740.
38. Biccard BM. Relationship between the inability to climb two flights of stairs and outcome after major noncardiac surgery: Implications for the preoperative assessment of functional capacity. Anaesthesia 2005; 60: 588-593.
39. Wiklund RA, Stein HD, Rosenbaum SH. Activities of daily living and cardiovascular complications following elective, noncardiac surgery. Yale J Biol Med 2001; 74: 75-87.
40. Morris CK, Ueshima K, Kawaguchi T, et al. The prognostic value of exercise capacity: A review of the literature. Am Heart J 1991; 122: 1423-1431.
41. Goldman L, Caldera DL, Nussbaum SR, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 1977; 297: 845-850.
42. Detsky AS, Abrams HB, Forbath N, et al. Cardiac assessment for patients undergoing noncardiac surgery. A multifactorial clinical risk index. Arch Intern Med 1986; 146: 2131-2134.
43. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100: 1043-1049.
44. Gupta PK, Gupta H, Sundaram A, et al. Development and validation of a risk calculator for prediction of cardiac risk after surgery. Circulation 2011; 124: 381-387.
45. Ford MK, Beattie WS, Wijeysundera DN. Systematic review: Prediction of perioperative cardiac complications and mortality by the revised cardiac risk index. Ann Intern Med 2010; 152: 26-35.
46. Maisel AS, Bhalla V, Braunwald E. Cardiac biomarkers: A contemporary status report. Nat Clin Pract Cardiovasc Med 2006; 3: 24-34.
47. Priebe HJ. Perioperative myocardial infarction -Aetiology and prevention. Br J Anaesth 2005; 95: 3-19.
48. Weber M, Luchner A, Seeberger M, et al. Incremental value of highsensitive troponin T in addition to the revised cardiac index for perioperative risk stratification in noncardiac surgery. Eur Heart J 2013; 34: 853-862.
49. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Eur Heart J 2012; 33: 2551-2567.
50. Wang TJ, Larson MG, Levy D, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004; 350: 655-663.
51. Dernellis J, Panaretou M. Assessment of cardiac risk before noncardiac surgery: Brain natriuretic peptide in 1590 patients. Heart 2006; 92: 1645-1650.
52. Rodseth RN, Padayachee L, Biccard BM. A meta-Analysis of the utility of preoperative brain natriuretic peptide in predicting early and intermediateterm mortality and major adverse cardiac events in vascular surgical patients. Anaesthesia 2008; 63: 1226-1233.
53. Karthikeyan G, Moncur RA, Levine O, et al. Is a preoperative brain natriuretic peptide or N-Terminal pro-B-Type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-Analysis of observational studies. J Am Coll Cardiol 2009; 54: 1599-1606.
54. Moonesinghe SR, Mythen MG, Das P, et al. Risk stratification tools for predicting morbidity and mortality in adult patients undergoing major surgery: Qualitative systematic review. Anesthesiology 2013; 119: 959-981.
55. Rodseth RN, Biccard BM, Le Manach Y, et al. The prognostic value of preoperative and postoperative B-Type natriuretic peptides in patients undergoing noncardiac surgery: B-Type natriuretic Peptide and N-Terminal fragment of pro-B-Type natriuretic Peptide: A systematic review and individual patient data meta-Analysis. J Am Coll Cardiol 2014; 63: 170-180.
56. Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013; 34: 2949-3003.
57. Jeger RV, Probst C, Arsenic R, et al. Long-Term prognostic value of the preoperative 12-lead electrocardiogram before major noncardiac surgery in coronary artery disease. Am Heart J 2006; 151: 508-513.
58. Halm EA, Browner WS, Tubau JF, et al. Echocardiography for assessing cardiac risk in patients having noncardiac surgery. Study of Perioperative Ischemia Research Group. Ann Intern Med 1996; 125: 433-441.
59. Rohde LE, Polanczyk CA, Goldman L, et al. Usefulness of transthoracic echocardiography as a tool for risk stratification of patients undergoing major noncardiac surgery. Am J Cardiol 2001; 87: 505-509.
60. Etchells E, Meade M, Tomlinson G, Cook D. Semiquantitative dipyridamole myocardial stress perfusion imaging for cardiac risk assessment before noncardiac vascular surgery: A metaanalysis. J Vasc Surg 2002; 36: 534-540.
61. Shaw LJ, Eagle KA, Gersh BJ, Miller DD. Meta-Analysis of intravenous dipyridamole-Thallium-201 imaging (1985 to 1994) and dobutamine echocardiography (1991 to 1994) for risk stratification before vascular surgery. J Am Coll Cardiol 1996; 27: 787-798.
62. Sicari R, Nihoyannopoulos P, Evangelista A, et al. Stress Echocardiography Expert Consensus Statement-Executive Summary: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur Heart J 2009; 30: 278-289.
63. Das MK, Pellikka PA, Mahoney DW, et al. Assessment of cardiac risk before nonvascular surgery: Dobutamine stress echocardiography in 530 patients. J Am Coll Cardiol 2000; 35: 1647-1653.
64. Raux M, Godet G, Isnard R, et al. Low negative predictive value of dobutamine stress echocardiography before abdominal aortic surgery. Br J Anaesth 2006; 97: 770-776.
65. Labib SB, Goldstein M, Kinnunen PM, Schick EC. Cardiac events in patients with negative maximal versus negative submaximal dobutamine echocardiograms undergoing noncardiac surgery: Importance of resting wall motion abnormalities. J Am Coll Cardiol 2004; 44: 82-87.
66. Nandalur KR, Dwamena BA, Choudhri AF, et al. Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease -A meta-Analysis. J Am Coll Cardiol 2007; 50: 1343-1353.
67. Schwitter J, Wacker CM, Wilke N, et al. MR-IMPACT II: Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary artery disease Trial: Perfusion-cardiac magnetic resonance vs. singlephoton emission computed tomography for the detection of coronary artery disease: A comparative multicentre, multivendor trial. Eur Heart J 2013; 34: 775-781.
68. Rerkpattanapipat P, Morgan TM, Neagle CM, et al. Assessment of preoperative cardiac risk with magnetic resonance imaging. Am J Cardiol 2002; 90: 416-419.
69. Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2012; 33: 2451-2496.
70. Knuuti J, Bengel F, Bax JJ, et al. Risks and benefits of cardiac imaging: An analysis of risks related to imaging for coronary artery disease. Eur Heart J 2013; 35: 633-638.
71. Schein OD, Katz J, Bass EB, et al. The value of routine preoperative medical testing before cataract surgery. Study of Medical Testing for Cataract Surgery. N Engl J Med 2000; 342: 168-175.
72. Patel MR, Bailey SR, Bonow RO, et al. ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization: A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Am Coll Cardiol 2012; 59: 1995-2027.
73. Hamm CW, Bassand JP, Agewall S, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011; 32: 2999-3054.
74. Wijns W, Kolh P, Danchin N, et al. Guidelines on myocardial revascularization. Eur Heart J 2010; 31: 2501-2555.
75. Steg PG, James SK, Atar D, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012; 33: 2569-2619.
76. Illuminati G, Ricco JB, Greco C, et al. Systematic preoperative coronary angiography and stenting improves postoperative results of carotid endarterectomy in patients with asymptomatic coronary artery disease: A randomised controlled trial. Eur J Vasc Endovasc Surg 2010; 39: 139-145.
77. Lüscher TF, Gersh B, Landmesser U, Ruschitzka F. Is the panic about beta-blockers in perioperative care justified? Eur Heart J 2014; epub ahead of print.
78. Devereaux PJ, Yang H, Yusuf S, et al. Effects of extended-release metoprolol succinate in patients undergoing noncardiac surgery (POISE trial): A randomised controlled trial. Lancet 2008; 371: 1839-1847.
79. Zaugg M, Bestmann L, Wacker J, et al. Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block -The Swiss Beta Blocker in Spinal Anesthesia (BBSA) study: A doubleblinded, placebo-controlled, multicenter trial with 1-year follow-up. Anesthesiology 2007; 107: 33-44.
80. Yang H, Raymer K, Butler R, et al. The effects of perioperative betablockade: Results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. Am Heart J 2006; 152: 983-990.
81. Juul AB, Grp DT. Effect of perioperative beta blockade in patients with diabetes undergoing major noncardiac surgery: Randomised placebo controlled, blinded multicentre trial. BMJ 2006; 332: 1482-1485.
82. Brady AR, Gibbs JS, Greenhalgh RM, et al. Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: Results of a randomized double-blind controlled trial. J Vasc Surg 2005; 41: 602-609.
83. Mangano DT, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. New Engl J Med 1996; 335: 1713-1720.
84. Alonso-Coello P, Paniagua P, Mizera R, Devereaux PJ. Should physicians initiate beta-blocker therapy in patients undergoing noncardiac surgery? Insights from the POISE trial. Pol Arch Med Wewn 2008; 118: 616-618.
85. Bouri S, Shun-Shin MJ, Cole GD, et al. Meta-Analysis of secure randomised controlled trials of beta-blockade to prevent perioperative death in noncardiac surgery. Heart 2014; 100: 456-464.
86. Angeli F, Verdecchia P, Karthikeyan G, et al. b-Blockers reduce mortality in patients undergoing high-risk noncardiac surgery. Am J Cardiovasc Drugs 2010; 10: 247-259.
87. Devereaux PJ, Beattie WS, Choi PT, et al. How strong is the evidence for the use of perioperative beta blockers in noncardiac surgery? Systematic review and meta-Analysis of randomised controlled trials. BMJ (Clinical research ed) 2005; 331: 313-321.
88. McGory ML, Maggard MA, Ko CY. A meta-Analysis of perioperative beta blockade: What is the actual risk reduction? Surgery 2005; 138: 171-179.
89. Stevens RD, Burri H, Tramer MR. Pharmacologic myocardial protection in patients undergoing noncardiac surgery: A quantitative systematic review. Anesth Analg 2003; 97: 623-633.
90. Wiesbauer F, Schlager O, Domanovits H, et al. Perioperative betablockers for preventing surgery-related mortality and morbidity: A systematic review and meta-Analysis. Anesth Analg 2007; 104: 27-41.
91. Auerbach AD, Goldman L. b-Blockers and reduction of cardiac events in noncardiac surgery: Scientific review. JAMA 2002; 287: 1435-1444.
92. Bangalore S, Wetterslev J, Pranesh S, et al. Perioperative beta blockers in patients having noncardiac surgery: A meta-Analysis. Lancet 2008; 372: 1962-1976.
93. Leibowitz AB. Can meta-Analysis of the current literature help determine if perioperative beta-blockers improve outcome of high-risk patients undergoing noncardiac surgery? J Cardiothorac Vasc Anesth 2010; 24: 217-218.
94. Beattie WS, Wijeysundera DN, Karkouti K, et al. Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials. Anesth Analg 2008; 106: 1039-1048.
95. Lindenauer PK, Pekow P, Wang KJ, et al. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 2005; 353: 349-361.
96. Shammash JB, Trost JC, Gold JM, et al. Perioperative beta-blocker withdrawal and mortality in vascular surgical patients. Am Heart J 2001; 141: 148-153.
97. London MJ, Hur K, Schwartz GG, Henderson WG. Association of perioperative beta-blockade with mortality and cardiovascular morbidity following major noncardiac surgery. JAMA 2013; 309: 1704-1713.
98. Wallace AW, Au S, Cason BA. Association of the pattern of use of perioperative beta-blockade and postoperative mortality. Anesthesiology 2010; 113: 794-805.
99. Kwon S, Thompson R, Florence M, et al. b-blocker continuation after noncardiac surgery: A report from the surgical care and outcomes assessment program. Arch Surg 2012; 147: 467-473.
100. Wallace AW, Au S, Cason BA. Perioperative beta-blockade: Atenolol is associated with reduced mortality when compared to metoprolol. Anesthesiology 2011; 114: 824-836.
101. Redelmeier D, Scales D, Kopp A. b-blockers for elective surgery in elderly patients: Population based, retrospective cohort study. BMJ (Clinical research ed) 2005; 331: 932.
102. Ashes C, Judelman S, Wijeysundera DN, et al. Selective b1-Antagonism with Bisoprolol Is Associated with Fewer Postoperative Strokes than Atenolol or Metoprolol: A Single-center Cohort Study of 44,092 Consecutive Patients. Anesthesiology 2013; 119: 777-787.
103. Ellenberger C, Tait G, Beattie WS. Chronic beta blockade is associated with a better outcome after elective noncardiac surgery than acute beta blockade: A single-center propensity-matched cohort study. Anesthesiology 2011; 114: 817-823.
104. Walsh M, Devereaux PJ, Garg AX, et al. Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: Toward an empirical definition of hypotension. Anesthesiology 2013; 119: 507-515.
105. Andersson C, Mérie C, Jørgensen M, et al. Association of b-Blocker Therapy With Risks of Adverse Cardiovascular Events and Deaths in Patients With Ischemic Heart Disease Undergoing Noncardiac Surgery: A Danish Nationwide Cohort Study. JAMA Intern Med 2014; 174: 336-344.
106. Wallace A, Layug B, Tateo I, et al. Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group. Anesthesiology 1998; 88: 7-17.
107. Lindenauer PK, Pekow P, Wang K, et al. Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery. JAMA 2004; 291: 2092-2099.
108. Hindler K, Shaw AD, Samuels J, et al. Improved postoperative outcomes associated with preoperative statin therapy. Anesthesiology 2006; 105: 1260-1272.
109. Desai H, Aronow WS, Ahn C, et al. Incidence of perioperative myocardial infarction and of 2-year mortality in 577 elderly patients undergoing noncardiac vascular surgery treated with and without statins. Arch Gerontol Geriatr 2010; 51: 149-151.
110. Lau WC, Froehlich JB, Jewell ES, et al. Impact of adding aspirin to betablocker and statin in high-risk patients undergoing major vascular surgery. Ann Vasc Surg 2013; 27: 537-545.
111. Durazzo AE, Machado FS, Ikeoka DT, et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: A randomized trial. J Vasc Surg 2004; 39: 967-975.
112. Chopra V, Wesorick DH, Sussman JB, et al. Effect of perioperative statins on death, myocardial infarction, atrial fibrillation, and length of stay: A systematic review and meta-Analysis. Arch Surg 2012; 147: 181-189.
113. Winchester DE, Wen X, Xie L, Bavry AA. Evidence of preprocedural statin therapy a meta-Analysis of randomized trials. J Am Coll Cardiol 2010; 56: 1099-1109.
114. Le Manach Y, Ibanez Esteves C, Bertrand M, et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing vascular surgery. Anesthesiology 2011; 114: 98-104.
115. Sanders RD, Nicholson A, Lewis SR, et al. Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery. Cochrane Database Syst Rev 2013; 7: CD009971.
116. McNally MM, Agle SC, Parker FM, et al. Preoperative statin therapy is associated with improved outcomes and resource utilization in patients undergoing aortic aneurysm repair. J Vasc Surg 2010; 51: 1390-1396.
117. Verzini F, De Rango P, Parlani G, et al. Effects of statins on early and late results of carotid stenting. J Vasc Surg 2011; 53: 71-79.
118. Le Manach Y, Godet G, Coriat P, et al. The impact of postoperative discontinuation or continuation of chronic statin therapy on cardiac outcome after major vascular surgery. Anesth Analg 2007; 104: 1326-1333.
119. Kertai MD, Westerhout CM, Varga KS, Acsady G, Gal J. Dihydropiridine calcium-channel blockers and perioperative mortality in aortic aneurysm surgery. Br J Anaesth 2008; 101: 458-465.
120. Devereaux PJ, Sessler DI, Leslie K, et al. Clonidine in patients undergoing noncardiac surgery. N Engl J Med 2014; 370: 1504-1513.
121. Burger W, Chemnitius JM, Kneissl GD, Rucker G. Low-dose aspirin for secondary cardiovascular prevention -cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation -review and meta-Analysis. J Int Med 2005; 257: 399-414.
122. Devereaux PJ, Mrkobrada M, Sessler DI, et al. Aspirin in patients undergoing noncardiac surgery. N Engl J Med 2014; 370: 1494-1503.
123. Patrono C, Andreotti F, Arnesen H, et al. Antiplatelet agents for the treatment and prevention of atherothrombosis. Eur Heart J 2011; 32: 2922-2932.
124. Korte W, Cattaneo M, Chassot PG, et al. Peri-operative management of antiplatelet therapy in patients with coronary artery disease: Joint position paper by members of the working group on Perioperative Haemostasis of the Society on Thrombosis and Haemostasis Research (GTH), the working group on Perioperative Coagulation of the Austrian Society for Anesthesiology, Resuscitation and Intensive Care (ÖGARI) and the Working Group Thrombosis of the European Society for Cardiology (ESC). Thromb Haemost 2011; 105: 743-749.
125. Sun JC, Whitlock R, Cheng J, et al. The effect of preoperative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: A systematic review of randomized and observational studies. Eur Heart J 2008; 29: 1057-1071.
126. Hawn MT, Graham LA, Richman JS, et al. Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents. JAMA 2013; 310: 1462-1472.
127. Huber KC, Evans MA, Bresnahan JF, et al. Outcome of noncardiac operations in patients with severe coronary-Artery disease successfully treated preoperatively with coronary angioplasty. Mayo Clin Proc 1992; 67: 15-21.
128. Kaluza GL, Joseph J, Lee JR, et al. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 2000; 35: 1288-1294.
129. Nuttall GA, Brown MJ, Stombaugh JW, et al. Time and cardiac risk of surgery after bare-metal stent percutaneous coronary intervention. Anesthesiology 2008; 109: 588-595.
130. Berger PB, Kleiman NS, Pencina MJ, et al. Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry. JACC Cardiovasc Interv 2010; 3: 920-927.
131. Baber U, Mehran R, Sharma SK, et al. Impact of the everolimus-eluting stent on stent thrombosis: A meta-Analysis of 13 randomized trials. J Am Coll Cardiol 2011; 58: 1569-1577.
132. Feres F, Costa RA, Abizaid A, et al. Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: The OPTIMIZE randomized trial. JAMA 2013; 310: 2510-2522.
133. Wijns W, Kolh P, Danchin N, et al. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2010; 31: 2501-2555.
134. Ferraris VA, Saha SP, Oestreich JH, et al. 2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations. Ann Thorac Surg 2012; 94: 1761-1781.
135. Mahla E, Suarez TA, Bliden KP, et al. Platelet function measurementbased strategy to reduce bleeding and waiting time in clopidogrel-Treated patients undergoing coronary artery bypass graft surgery: The timing based on platelet function strategy to reduce clopidogrel-Associated bleeding related to CABG (TARGET-CABG) study. Circ Cardiovasc Interv 2012; 5: 261-269.
136. Angiolillo DJ, Firstenberg MS, Price MJ, et al. Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: A randomized controlled trial. JAMA 2012; 307: 265-274.
137. Pengo V, Cucchini U, Denas G, et al. Standardized Low-Molecular-Weight Heparin Bridging Regimen in Outpatients on Oral Anticoagulants Undergoing Invasive Procedure or Surgery: An Inception Cohort Management Study. Circulation 2009; 119: 2920-2927.
138. Huber K, Connolly SJ, Kher A, et al. Practical use of dabigatran etexilate for stroke prevention in atrial fibrillation. Int J Clin Pract 2013; 67: 516-526.
139. De Caterina R, Husted S, Wallentin L, et al. New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper. J Am Coll Cardiol 2012; 59: 1413-1425.
140. Heidbuchel H, Verhamme P, Alings M, et al. European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with nonvalvular atrial fibrillation. Europace 2013; 15: 625-651.
141. Weitz JI, Quinlan DJ, Eikelboom JW. Periprocedural management and approach to bleeding in patients taking dabigatran. Circulation 2012; 126: 2428-2432.
142. Eerenberg ES, Kamphuisen PW, Sijpkens MK, et al. Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: A randomized, placebo-controlled, crossover study in healthy subjects. Circulation 2011; 124: 1573-1579.
143. Díaz MQ, Borobia AM, Núñez MA, et al. Use of prothrombin complex concentrates for urgent reversal of dabigatran in the Emergency Department. Haematologica 2013; 98: E143-e144.
144. Camm AJ, Lip GY, De Caterina R, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 2012; 33: 2719-2747.
145. Dawood MM, Gutpa DK, Southern J, et al. Pathology of fatal perioperative myocardial infarction: Implications regarding pathophysiology and prevention. Int J Cardiol 1996; 57: 37-44.
146. Devereaux PJ, Goldman L, Cook DJ, et al. Perioperative cardiac events in patients undergoing noncardiac surgery: A review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. CMAJ 2005; 173: 627-634.
147. Eagle KA, Rihal CS, Mickel MC, et al. Cardiac risk of noncardiac surgery -Influence of coronary disease and type of surgery in 3368 operations. Circulation 1997; 96: 1882-1887.
148. Mookadam F, Carpenter SD, Thota VR, et al. Risk of adverse events after coronary artery bypass graft and subsequent noncardiac surgery. Future Cardiol 2011; 7: 69-75.
149. Assali A, Vaknin-Assa H, Lev E, et al. The risk of cardiac complications following noncardiac surgery in patients with drug eluting stents implanted at least six months before surgery. Catheter Cardiovasc Interv 2009; 74: 837-843.
150. Wijeysundera DN, Wijeysundera HC, Yun L, et al. Risk of elective major noncardiac surgery after coronary stent insertion: A population-based study. Circulation 2012; 126: 1355-1362.
151. Brilakis ES, Orford JL, Fasseas P, et al. Outcome of patients undergoing balloon angioplasty in the two months prior to noncardiac surgery. Am J Cardiol 2005; 96: 512-514.
152. McFalls EO, Ward HB, Moritz TE, et al. Coronary-Artery revascularization before elective major vascular surgery. New Engl J Med 2004; 351: 2795-2804.
153. Monaco M, Stassano P, Di Tommaso L, et al. Systematic strategy of prophylactic coronary angiography improves long-Term outcome after major vascular surgery in medium-To high-risk patients: A prospective, randomized study. J Am Coll Cardiol 2009; 54: 989-996.
154. Wong EY, Lawrence HP, Wong DT. The effects of prophylactic coronary revascularization or medical management on patient outcomes after noncardiac surgery-A meta-Analysis. Can J Anaesth 2007; 54: 705-717.
155. Mohr FW, Morice MC, Kappetein AP, et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with threevessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet 2013; 381: 629-638.
156. Matteau A, Mauri L. Optimal timing of noncardiac surgery after stents. Circulation 2012; 126: 1322-1324.
157. Bangalore S, Kumar S, Fusaro M, et al. Short-And long-Term outcomes with drug-eluting and bare-metal coronary stents: A mixed-Treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials. Circulation 2012; 125: 2873-2891.
158. Livhits M, Gibbons MM, de Virgilio C, et al. Coronary revascularization after myocardial infarction can reduce risks of noncardiac surgery. J Am Coll Surg 2011; 212: 1018-1026.
159. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012; 14: 803-869.
160. Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart 2007; 93: 1137-1146.
161. Sabaté S, Mases A, Guilera N, et al. Incidence and predictors of major perioperative adverse cardiac and cerebrovascular events in noncardiac surgery. Br J Anaesth 2011; 107: 879-890.
162. Pannell LM, Reyes EM, Underwood SR. Cardiac risk assessment before noncardiac surgery. Eur Heart J Cardiovasc Imaging 2013; 14: 316-322.
163. Hammill BG, Curtis LH, Bennett-Guerrero E, et al. Impact of heart failure on patients undergoing major noncardiac surgery. Anesthesiology 2008; 108: 559-567.
164. Upshaw J, Kiernan MS. Preoperative cardiac risk assessment for noncardiac surgery in patients with heart failure. Curr Heart Fail Rep 2013; 10: 147-156.
165. Kazmers A, Cerqueira MD, Zierler RE. Perioperative and late outcome in patients with left ventricular ejection fraction of 35% or less who require major vascular surgery. J Vasc Surg 1988; 8: 307-315.
166. Xu-Cai YO, Brotman DJ, Phillips CO, et al. Outcomes of patients with stable heart failure undergoing elective noncardiac surgery. Mayo Clin Proc 2008; 83: 280-288.
167. Healy KO, Waksmonski CA, Altman RK, et al. Perioperative outcome and long-Term mortality for heart failure patients undergoing intermediate-And high-risk noncardiac surgery: Impact of left ventricular ejection fraction. Congest Heart Fail 2010; 16: 45-49.
168. Meta-Analysis global group in chronic heart failure (MAGGIC). The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: An individual patient data meta-Analysis. Eur Heart J 2012; 33: 1750-1757.
169. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification. Eur J Echocardiogr 2006; 7: 79-108.
170. Mor-Avi V, Lang RM, Badano LP, et al. Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. Eur J Echocardiogr 2011; 12: 167-205.
171. Cowie B. Focused transthoracic echocardiography predicts perioperative cardiovascular morbidity. J Cardiothorac Vasc Anesth 2012; 26: 989-993.
172. Wijeysundera DN, Beattie WS, Karkouti K, et al. Association of echocardiography before major elective noncardiac surgery with postoperative survival and length of hospital stay: Population based cohort study. BMJ 2011; 342: D3695.
173. Canty DJ, Royse CF, Kilpatrick D, et al. The impact on cardiac diagnosis and mortality of focused transthoracic echocardiography in hip fracture surgery patients with increased risk of cardiac disease: A retrospective cohort study. Anaesthesia 2012; 67: 1202-1209.
174. Raman SV, Simonetti OP. The CMR examination in heart failure. Heart Fail Clin 2009; 5: 283-300.
175. Biccard BM, Lurati Buse GA, Burkhart C, et al. The influence of clinical risk factors on preoperative B-Type natriuretic peptide risk stratification of vascular surgical patients. Anaesthesia 2012; 67: 55-59.
176. Rajagopalan S, Croal BL, Reeve J, et al. N-Terminal pro-B-Type natriuretic peptide is an independent predictor of all-cause mortality and MACE after major vascular surgery in medium-Term follow-up. Eur J Vasc Endovasc Surg 2011; 41: 657-662.
177. Guazzi M, Adams V, Conraads V, et al. EACPR/AHA Joint Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Eur Heart J 2012; 33: 2917-2927.
178. Young EL, Karthikesalingam A, Huddart S, et al. A systematic review of the role of cardiopulmonary exercise testing in vascular surgery. Eur J Vasc Endovasc Surg 2012; 44: 64-71.
179. Smith TB, Stonell C, Purkayastha S, Paraskevas P. Cardiopulmonary exercise testing as a risk assessment method in non cardio-pulmonary surgery: A systematic review. Anaesthesia 2009; 64: 883-893.
180. Rosenman DJ, McDonald FS, Ebbert JO, et al. Clinical consequences of withholding versus administering renin-Angiotensin-Aldosterone system antagonists in the preoperative period. J Hosp Med 2008; 3: 319-325.
181. Howell SJ, Sear JW, Foëx P. Hypertension, hypertensive heart disease and perioperative cardiac risk. Br J Anaesth 2004; 92: 570-583.
182. Casadei B, Abuzeid H. Is there a strong rationale for deferring elective surgery in patients with poorly controlled hypertension? J Hypertens 2005; 23: 19-22.
183. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013; 34: 2159-2219.
184. Kihara S, Brimacombe J, Yaguchi Y, et al. Hemodynamic responses among three tracheal intubation devices in normotensive and hypertensive patients. Anesth Analg 2003; 96: 890-895.
185. Charlson ME, MacKenzie CR, Gold JP, et al. Intraoperative blood pressure. What patterns identify patients at risk for postoperative complications? Ann Surg 1990; 212: 567-580.
186. Weksler N, Klein M, Szendro G, et al. The dilemma of immediate preoperative hypertension: To treat and operate, or to postpone surgery? J Clin Anesth 2003; 15: 179-183.
187. Goldman L, Caldera DL. Risks of general anesthesia and elective operation in the hypertensive patient. Anesthesiology 1979; 50: 285-292.
188. Calleja AM, Dommaraju S, Gaddam R, et al. Cardiac risk in patients aged >75 years with asymptomatic, severe aortic stenosis undergoing noncardiac surgery. Am J Cardiol 2010; 105: 1159-1163.
189. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol 2007; 50: E159-e241.
190. Habib G, Hoen B, Tornos P, et al.Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 2009; 30: 2369-2413.
191. Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death-executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur Heart J 2006; 27: 2099-2140.
192. Drew BJ, Ackerman MJ, Funk M, et al. Prevention of torsade de pointes in hospital settings: A scientific statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol 2010; 55: 934-947.
193. Balser JR, Martinez EA, Winters BD, et al. Beta-Adrenergic blockade accelerates conversion of postoperative supraventricular tachyarrhythmias. Anesthesiology 1998; 89: 1052-1059.
194. Healey JS, Merchant R, Simpson C, et al. Canadian Cardiovascular Society/Canadian Anesthesiologists' Society/Canadian Heart Rhythm Society joint position statement on the perioperative management of patients with implanted pacemakers, defibrillators, and neurostimulating devices. Can J Cardiol 2012; 28: 141-151.
195. Bihorac A, Yavas S, Subbiah S, et al. Long-Term risk of mortality and acute kidney injury during hospitalization after major surgery. Ann Surg 2009; 249: 851-858.
196. Kheterpal S, Tremper KK, Heung M, et al. Development and validation of an acute kidney injury risk index for patients undergoing general surgery: Results from a national data set. Anesthesiology 2009; 110: 505-515.
197. Earley A, Miskulin D, Lamb EJ, et al. Estimating equations for glomerular filtration rate in the era of creatinine standardization: A systematic review. Ann Intern Med 2012; 156: 785-795.
198. KDIGO Clinical Practice Guideline for Acute Kidney Injury. In: Kidney Int Suppl. 2012; 2(suppl2): 1-138.
199. Kellum JA, Lameire N. Group ftKAGW Diagnosis, evaluation, and management of acute kidney injury: A KDIGO summary (Part 1). Crit Care 2013; 17: 204.
200. McCullough PA, Soman SS. Contrast-induced nephropathy. Crit Care Clin 2005; 21: 261-80.
201. Cruz DN, Goh CY, Marenzi G, et al. Renal replacement therapies for prevention of radiocontrast-induced nephropathy: A systematic review. Am J Med 2012; 125: 66-78; e3.
202. Jang JS, Jin HY, Seo JS, et al. Sodium bicarbonate therapy for the prevention of contrast-induced acute kidney injury -A systematic review and meta-Analysis. Circ J 2012; 76: 2255-2265.
203. Leoncini M, Toso A, Maioli M, et al. Early high-dose rosuvastatin for Contrast-Induced Nephropathy Prevention in Acute Coronary Syndrome. Results from Protective effect of Rosuvastatin and Antiplatelet Therapy on contrast-induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome (PRATO-ACS Study). J Am Coll Cardiol 2013; 63: 71-79.
204. Selim M. Perioperative stroke. N Engl J Med 2007; 356: 706-713.
205. Macellari F, Paciaroni M, Agnelli G, Caso V. Perioperative stroke risk in nonvascular surgery. Cerebrovasc Dis 2012; 34: 175-181.
206. Mashour GA, Shanks AM, Kheterpal S. Perioperative stroke and associated mortality after noncardiac, nonneurologic surgery. Anesthesiology 2011; 114: 1289-1296.
207. Ng JL, Chan MT, Gelb AW. Perioperative stroke in noncardiac, nonneurosurgical surgery. Anesthesiology 2011; 115: 879-890.
208. Ahmed B, Al-Khaffaf H. Prevalence of significant asymptomatic carotid artery disease in patients with peripheral vascular disease: A metaanalysis. Eur J Vasc Endovasc Surg 2009; 37: 262-271.
209. Hofmann R, Kypta A, Steinwender C, et al. Coronary angiography in patients undergoing carotid artery stenting shows a high incidence of significant coronary artery disease. Heart 2005; 91: 1438-1441.
210. Perk J, De Backer G, Gohlke H, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2012; 33: 1635-1701.
211. Tendera M, Aboyans V, Bartelink ML, et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: The Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J 2011; 32: 2851-2906.
212. Ashton CM, Petersen NJ, Wray NP, et al. The incidence of perioperative myocardial infarction in men undergoing noncardiac surgery. Ann Intern Med 1993; 118: 504-510.
213. Sin DD, Wu LL, Man SFP. The relationship between reduced lung function and cardiovascular mortality -A population-based study and a systematic review of the literature. Chest 2005; 127: 1952-1959.
214. Canet J, Gallart L, Gomar C, et al. Prediction of postoperative pulmonary complications in a population-based surgical cohort. Anesthesiology 2010; 113: 1338-1350.
215. Edrich T, Sadovnikoff N. Anesthesia for patients with severe chronic obstructive pulmonary disease. Curr Opin Anaesthesiol 2010; 23: 18-24.
216. Chau EH, Lam D, Wong J, et al. Obesity hypoventilation syndrome: A review of epidemiology, pathophysiology, and perioperative considerations. Anesthesiology 2012; 117: 188-205.
217. Galiè N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009; 30: 2493-2537.
218. Ramakrishna G, Sprung J, Ravi BS, et al. Impact of pulmonary hypertension on the outcomes of noncardiac surgery. J Am Coll Cardiol 2005; 45: 1691-1699.
219. Kaw R, Pasupuleti V, Deshpande A, et al. Pulmonary hypertension: An important predictor of outcomes in patients undergoing noncardiac surgery. Respir Med 2011; 105: 619-624.
220. Gille J, Seyfarth HJ, Gerlach S, et al. Perioperative anesthesiological management of patients with pulmonary hypertension. Anesthesiol Res Pract 2012; 2012: 356982.
221. Price LC, Wort SJ, Finney SJ, et al. Pulmonary vascular and right ventricular dysfunction in adult critical care: Current and emerging options for management: A systematic literature review. Crit Care 2010; 14: R169.
222. Baumgartner H, Bonhoeffer P, De Groot NM, et al. ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J 2010; 31: 2915-2957.
223. Landesberg G, Luria MH, Cotev S, et al. Importance of long-duration postoperative ST-segment depression in cardiac morbidity after vascular surgery. Lancet 1993; 341: 715-719.
224. Leung JM, Voskanian A, Bellows WH, Pastor D. Automated electrocardiograph ST segment trending monitors: Accuracy in detecting myocardial ischemia. Anesth Analg 1998; 87: 4-10.
225. Landesberg G, Mosseri M, Wolf Y, et al. Perioperative myocardial ischemia and infarction -Identification by continuous 12-lead electrocardiogram with online ST-segment monitoring. Anesthesiology 2002; 96: 264-270.
226. London MJ, Hollenberg M, Wong MG, et al. Intraoperative myocardial ischemia: Localization by continuous 12-lead electrocardiography. Anesthesiology 1988; 69: 232-241.
227. Martinez EA, Kim LJ, Faraday N, et al. Sensitivity of routine intensive care unit surveillance for detecting myocardial ischemia. Crit Care Med 2003; 31: 2302-2308.
228. Landesberg G, Shatz V, Akopnik I, et al. Association of cardiac troponin, CK-MB, and postoperative myocardial ischemia with long-Term survival after major vascular surgery. J Am Coll Cardiol 2003; 42: 1547-1554.
229. London MJ, Tubau JF, Wong MG, et al. The 'natural history' of segmental wall motion abnormalities in patients undergoing noncardiac surgery. S.P.I Research Group. Anesthesiology 1990; 73: 644-655.
230. Eisenberg MJ, London MJ, Leung JM, et al. Monitoring for myocardial ischemia during noncardiac surgery. A technology assessment of transesophageal echocardiography and 12-lead electrocardiography. The Study of Perioperative Ischemia Research Group. JAMA 1992; 268: 210-216.
231. Thys DM, Abel M, Bollen BA, et al. Practice guidelines for perioperative transesophageal echocardiography -A report by the American Society of Anesthesiologists and the Society of Cardiovascular Anesthesiologists Task Force on Transesophageal Echocardiography. Anesthesiology 1996; 84: 986-1006.
232. Schulmeyer C, Farías J, Rajdl E, et al. Utility of transesophageal echocardiography during severe hypotension in noncardiac surgery. Rev Bras Anestesiol 2010; 60: 513-521.
233. Agency of Healthcare Research and Quality (AHRQ) Technology Assessment Program: Oesophageal Doppler ultrasound-based cardiac output monitoring for real-Time therapeutic management of hospitalized patient. MD, USA: Agency of Healthcare Research and Quality, 2007.
234. NHS Technology Adoption Centre. How to why to guides: Doppler guided intraoperative fluid management. Manchester, 2010. http://webarchive.nationalarchives.gov.uk/20130701143131/http://www.ntac.nhs.uk/HowToWhyToGuides/DopplerGuidedIntraoperative/Doppler-Executive-Summary.aspx (accessed 1 August 2014)
235. Echocardiography ASoAaSoCATFoT. Practice guidelines for perioperative transesophageal echocardiography. An updated report by the American Society of Anesthesiologists and the Society of Cardiovascular Anesthesiologists Task Force on Transesophageal Echocardiography. Anesthesiology 2010; 112: 1084-1096.
236. Polanczyk CA, Rohde LE, Goldman L, et al. Right heart catheterization and cardiac complications in patients undergoing noncardiac surgery -An observational study. JAMA 2001; 286: 309-314.
237. Rajaram SS, Desai NK, Kalra A, et al. Pulmonary artery catheters for adult patients in intensive care. Cochrane Database Syst Rev 2013; 2: CD003408.
238. Gan TJ, Soppitt A, Maroof M, et al. Goal-directed intraoperative fluid administration reduces length of hospital stay after major surgery. Anesthesiology 2002; 97: 820-826.
239. IDF Diabetes Atlas, 6th edn. Brussels, Belgium: International Diabetes Federation, 2013.
240. Marik PE, Preiser JC. Toward understanding tight glycemic control in the ICU: A systematic review and metaanalysis. Chest 2010; 137: 544-551.
241. Jacobi J, Bircher N, Krinsley J, et al. Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med 2012; 40: 3251-3276.
242. Rydén L, Grant PJ, Anker SD, et al. ESC Guidelines on diabetes, prediabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force on diabetes, prediabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J 2013; 34: 3035-3087.
243. Pottie K, Jaramillo A, Lewin G, et al. Recommendations on screening for type 2 diabetes in adults. CMAJ 2012; 184: 1687-1696.
244. De Hert S, Imberger G, Carlisle J, et al. Preoperative evaluation of the adult patient undergoing noncardiac surgery: Guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 2011; 28: 684-722.
245. Bijker JB, Persoon S, Peelen LM, et al. Intraoperative hypotension and perioperative ischemic stroke after general surgery: A nested case-control study. Anesthesiology 2012; 116: 658-664.
246. Sessler DI, Sigl JC, Kelley SD, et al. Hospital stay and mortality are increased in patients having a 'triple low' of low blood pressure, low bispectral index, and low minimum alveolar concentration of volatile anesthesia. Anesthesiology 2012; 116: 1195-1203.
247. Landoni G, Greco T, Biondi-Zoccai G, et al. Anaesthetic drugs and survival: A Bayesian network meta-Analysis of randomized trials in cardiac surgery. Br J Anaesth 2013; 111: 886-896.
248. Van der Linden PJ, Dierick A, Wilmin S, et al. A randomized controlled trial comparing an intraoperative goal-directed strategy with routine clinical practice in patients undergoing peripheral arterial surgery. Eur J Anaesthesiol 2010; 27: 788-793.
249. Zangrillo A, Testa V, Aldrovandi V, et al. Volatile agents for cardiac protection in noncardiac surgery: A randomized controlled study. J Cardiothorac Vasc Anesth 2011; 25: 902-907.
250. Lurati Buse GA, Schumacher P, Seeberger E, et al. Randomized comparison of sevoflurane versus propofol to reduce perioperative myocardial ischemia in patients undergoing noncardiac surgery. Circulation 2012; 126: 2696-2704.
251. De Hert SG. Cardioprotection by volatile anesthetics: What about noncardiac surgery? J Cardiothorac Vasc Anesth 2011; 25: 899-901.
252. Rodgers A, Walker N, Schug S, et al. Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: Results from overview of randomised trials. BMJ 2000; 321: 1493-1497.
253. Wu CL, Rowlingson AJ, Herbert R, et al. Correlation of postoperative epidural analgesia on morbidity and mortality after colectomy in Medicare patients. J Clin Anesth 2006; 18: 594-599.
254. Bode RH, Lewis KP, Zarich SW, et al. Cardiac outcome after peripheral vascular surgery -Comparison of general and regional anesthesia. Anesthesiology 1996; 84: 3-13.
255. Mauermann WJ, Shilling AM, Zuo Z. A comparison of neuraxial block versus general anesthesia for elective total hip replacement: A metaanalysis. Anesth Analg 2006; 103: 1018-1025.
256. Rigg JRA, Jamrozik K, Myles PS, et al. Epidural anaesthesia and analgesia and outcome of major surgery: A randomised trial. Lancet 2002; 359: 1276-1282.
257. Memtsoudis SG, Sun X, Chiu YL, et al. Perioperative comparative effectiveness of anesthetic technique in orthopedic patients. Anesthesiology 2013; 118: 1046-1058.
258. Barbosa FT, Jucá MJ, Castro AA, Cavalcante JC. Neuraxial anaesthesia for lower-limb revascularization. Cochrane Database Syst Rev 2013; 7: CD007083.
259. Gogarten W, Vandermeulen E, Van Aken H, et al. Regional anaesthesia and antithrombotic agents: Recommendations of the European Society of Anaesthesiology. Eur J Anaesthesiol 2010; 27: 999-1015.
260. Leslie K, Myles P, Devereaux P, et al. Neuraxial block, death and serious cardiovascular morbidity in the POISE trial. Br J Anaesth 2013; 111: 382-390.
261. Hamilton MA, Cecconi M, Rhodes A. A systematic review and metaanalysis on the use of preemptive hemodynamic intervention to improve postoperative outcomes in moderate and high-risk surgical patients. Anesth Analg 2011; 112: 1392-1402.
262. Grocott MP, Dushianthan A, Hamilton MA, et al. Perioperative increase in global blood flow to explicit defined goals and outcomes following surgery. Cochrane Database Syst Rev 2012; 11: CD004082.
263. Cecconi M, Corredor C, Arulkumaran N, et al. Clinical review: Goaldirected therapy-what is the evidence in surgical patients? The effect on different risk groups. Crit Care 2013; 17: 209.
264. Arulkumaran N, Corredor C, Hamilton MA, et al. Cardiac complications associated with goal-directed therapy in high-risk surgical patients: A meta-Analysis. Br J Anaesth 2014; 112: 648-659.
265. Haynes AB, Regenbogen SE, Weiser TG, et al. Surgical outcome measurement for a global patient population: Validation of the Surgical Apgar Score in 8 countries. Surgery 2011; 149: 519-524.
266. Rodseth RN, Biccard BM, Chu R, et al. Postoperative B-Type natriuretic peptide for prediction of major cardiac events in patients undergoing noncardiac surgery: Systematic review and individual patient metaanalysis. Anesthesiology 2013; 119: 270-283.
267. Ghaferi AA, Birkmeyer JD, Dimick JB. Variation in hospital mortality associated with inpatient surgery. N Engl J Med 2009; 361: 1368-1375.
268. Levy M, Heels-Ansdell D, Hiralal R, et al. Prognostic value of troponin and creatine kinase muscle and brain isoenzyme measurement after noncardiac surgery: A systematic review and meta-Analysis. Anesthesiology 2011; 114: 796-806.
269. Ausset S, Auroy Y, Verret C, et al. Quality of postoperative care after major orthopedic surgery is correlated with both long-Term cardiovascular outcome and troponin Ic elevation. Anesthesiology 2010; 113: 529-540.
270. Liu SS, Wu CL. The effect of analgesic technique on postoperative patient-reported outcomes including analgesia: A systematic review. Anesth Analg 2007; 105: 789-808.
271. White PF, Kehlet H. Postoperative pain management and patient outcome: Time to return to work!. Anesth Analg 2007; 104: 487-489.
272. Pöpping DM, Elia N, Van Aken HK, et al. Impact of Epidural Analgesia on Mortality and Morbidity After Surgery: Systematic Review and Metaanalysis of Randomized Controlled Trials. Ann Surg 2013.
273. Clarke H, Bonin RP, Orser BA, et al. The prevention of chronic postsurgical pain using gabapentin and pregabalin: A combined systematic review and meta-Analysis. Anesth Analg 2012; 115: 428-442.
274. Dolin SJ, Cashman JN, Bland JM. Effectiveness of acute postoperative pain management: I Evidence from published data. Br J Anaesth 2002; 89: 409-423.
275. Jørgensen H, Wetterslev J, Møiniche S, Dahl JB. Epidural local anaesthetics versus opioid-based analgesic regimens on postoperative gastrointestinal paralysis, PONV and pain after abdominal surgery. Cochrane Database Syst Rev 2000; CD001893.
276. Block BM, Liu SS, Rowlingson AJ, et al. Efficacy of postoperative epidural analgesia -A meta-Analysis. JAMA 2003; 290: 2455-2463.
277. Bhala N, Emberson J, Merhi A, et al. Vascular and upper gastrointestinal effects of nonsteroidal anti-inflammatory drugs: Meta-Analyses of individual participant data from randomised trials. Lancet 2013; 382: 769-779.
278. Schug SA, Manopas A. Update on the role of nonopioids for postoperative pain treatment. Best Pract Res Clin Anaesthesiol 2007; 21: 15-30.
279. Varas-Lorenzo C, Riera-Guardia N, Calingaert B, et al. Myocardial infarction and individual nonsteroidal anti-inflammatory drugs metaanalysis of observational studies. Pharmacoepidemiol Drug Saf 2013; 22: 559-570